US In Vitro Diagnostics Market by Application (Diabetes, Cancer, Infectious Diseases, Cardiology), Technology (Molecular Diagnostics, Chairs & Stools, Bath Lifts, Microbiology), End User (Laboratories, Hospitals) & by Region – Forecast to 2021 to 2026

$3,850.00$5,850.00

Published on: March 24, 2021
Clear
SKU: GMS-3085 Category:

OVERVIEW

The U.S. IVD Market is projected to rise at a CAGR of 5.4% from 2021 to 2026, owing to the COVID-19 pandemic. The market is being driven by rising demand for early and reliable disease detection, increased adoption of fully automated instruments and automation in laboratories, increased adoption of point-of-care research, and increased knowledge of personalized medicine. The study forecasts short- and long-term developments that will affect the market’s future, including the effect of the COVID-19 pandemic on the industry.

US In Vitro Diagnostics Market by Application (Diabetes, Cancer, Infectious Diseases, Cardiology), Technology (Molecular Diagnostics, Chairs & Stools, Bath Lifts, Microbiology), End User (Laboratories, Hospitals) & by Region - Forecast to 2021 to 2026 1

US In Vitro Diagnostics Market by Application (Diabetes, Cancer, Infectious Diseases, Cardiology), Technology (Molecular Diagnostics, Chairs & Stools, Bath Lifts, Microbiology), End User (Laboratories, Hospitals) & by Region - Forecast to 2021 to 2026 2

US In Vitro Diagnostics Market by Application (Diabetes, Cancer, Infectious Diseases, Cardiology), Technology (Molecular Diagnostics, Chairs & Stools, Bath Lifts, Microbiology), End User (Laboratories, Hospitals) & by Region - Forecast to 2021 to 2026 3

US In Vitro Diagnostics Market by Application (Diabetes, Cancer, Infectious Diseases, Cardiology), Technology (Molecular Diagnostics, Chairs & Stools, Bath Lifts, Microbiology), End User (Laboratories, Hospitals) & by Region - Forecast to 2021 to 2026 4

US In Vitro Diagnostics Market by Application (Diabetes, Cancer, Infectious Diseases, Cardiology), Technology (Molecular Diagnostics, Chairs & Stools, Bath Lifts, Microbiology), End User (Laboratories, Hospitals) & by Region - Forecast to 2021 to 2026 5

US In Vitro Diagnostics Market by Application (Diabetes, Cancer, Infectious Diseases, Cardiology), Technology (Molecular Diagnostics, Chairs & Stools, Bath Lifts, Microbiology), End User (Laboratories, Hospitals) & by Region - Forecast to 2021 to 2026 6

US In Vitro Diagnostics Market by Application (Diabetes, Cancer, Infectious Diseases, Cardiology), Technology (Molecular Diagnostics, Chairs & Stools, Bath Lifts, Microbiology), End User (Laboratories, Hospitals) & by Region - Forecast to 2021 to 2026 7

US In Vitro Diagnostics Market by Application (Diabetes, Cancer, Infectious Diseases, Cardiology), Technology (Molecular Diagnostics, Chairs & Stools, Bath Lifts, Microbiology), End User (Laboratories, Hospitals) & by Region - Forecast to 2021 to 2026 8

TABLE OF CONTENT

1 U.S. In Vitro Diagnostics (IVD) Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 U.S. In Vitro Diagnostics (IVD) Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 U.S. In Vitro Diagnostics (IVD) Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis

5 U.S. In Vitro Diagnostics (IVD) Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies

6 U.S. In Vitro Diagnostics (IVD) Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes

7 U.S. In Vitro Diagnostics (IVD) Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Supplier and distributor analysis (Market share and product dealing strategies)

8 U.S. In Vitro Diagnostics (IVD) Market – By Product (Market Size – & million/billion)
8.1 Reagents & Kits
8.2 Instruments
8.3 Services

9 U.S. In Vitro Diagnostics (IVD) Market – By Technology
9.1 Immunoassay
9.2 Hematology
9.3 Clinical Chemistry
9.4 Molecular Diagnostics
9.5 Coagulation
9.6 Microbiology
9.7 Others

10 U.S. In Vitro Diagnostics (IVD) Market – By Application
10.1 Infectious Diseases
10.2 Diabetes
10.3 Autoimmune Diseases
10.4 Nephrology
10.5 Oncology
10.6 Cardiology
10.7 Drug Testing/Pharmacogenomics
10.8 HIV/Aids
10.9 Other

11 U.S. In Vitro Diagnostics (IVD) Market – By End-User
11.1 Hospitals
11.2 Laboratories
11.3 Point-Of-Care Testing
11.4 Patient Self-Testing
11.5 Academic Institutes

12 U.S. In Vitro Diagnostics (IVD) Market – Entropy
12.1 New product launches
12.2 M&A’s, collaborations, JVs and partnerships

13 U.S. In Vitro Diagnostics (IVD) Market Company Profile (Key Players)
13.1 Market Share, Company Revenue, Products, M&A, Developments
13.2 Thermo Fisher Scientific
13.3 Siemens AG
13.4 Sysmex Corporation
13.5 Danaher Corporation
13.6 Johnson & Johnson
13.7 Agilent Technologies
13.8 Roche Diagnostics
13.9 Becton, Dickinson and Company
13.10 Bio-Rad Laboratories, Inc.
13.11 Qiagen
13.12 Company 11 & more

14 U.S. In Vitro Diagnostics (IVD) Market – Appendix
14.1 Sources
14.2 Abbreviations